C O M M U N I C A T I O N S
Scheme 2a
Figure 1. Schematic illustration of generating and analyzing a defined CPD
lesion (red stretch in the plasmid strand) in genomic M13 mp 18 ss DNA.
specifically the targeted sequence in a large genomic DNA fragment
in order to generate selectively upon irradiation the desired cis-
syn dTddT lesion. In summary, we have created novel reagents
that allow synthesis of cis-syn dTddT lesions directly in single-
stranded DNA and even in large genomic DNA.
a Procedure to create a CPD lesion (red) in a 51mer DNA. It is possible
to generate the CPD lesion in only one of the two TT sites, which is analyzed
by subsequent enzymatic digestion and HPLC-MS/MS.
Acknowledgment. We thank the Deutsche Forschungsgemein-
schaft (DFG), the Volkswagen Foundation, the EU Marie Curie
Training and Mobility Program (CLUSTOXDNA), and the Fonds
der Chemischen Industrie for generous financial support of this
research. We thank D. Hammond for proofreading the manuscript.
electrophoresis. The strands were then fully digested with an
enzyme mixture containing nuclease P1, calf spleen phosphodi-
esterase II, alkaline phosphatase (CIP), and snake Venom phos-
phodiesterase I. The two digests were analyzed by HPLC-MS/
MS (Scheme 2). The mass spectra show the peaks for the canonical
nucleobases dA, dC, dG, and dT. Only for the small fragment was
a large additional signal for a dTddT dimer at m/z ) 545 recorded.
The fragmentation pattern of this signal was analyzed by HPLC-
MS/MS and proven to be identical with reported data for a cis-
syn dTddT, proving the correct stereochemistry.13 The results show
that the PNA reagents bind specifically to the wanted sequence in
the DNA strand in order to specifically direct the formation of cis-
syn dTddT. Formation of other lesions, such as (6-4) photoad-
ducts, or trans-syn photo products can be ruled out based on the
mass fragmentation data.
We finally investigated the ability to form site-specifically a dTd
dT lesion directly in genomic DNA. This was tested with a M13
mp 18 phage genome (7249 nucleobases), which was prepared in
the form of a cyclic single strand (Figure 1). The PNA reagent
PNA13 was prepared and hybridized to the genomic DNA, and
the PNA:DNA ds was irradiated for 3 h. The PNA was then
removed using reversed-phase HPLC at 55 °C. A biotin-labeled
oligonucleotide (DNAB, 5′-TCG-CCA-TTC-AGG-CTG-CGC-AAC-
TGT-TBGG-GAA-GGG-CGA-TCG-GT-3′ with TB ) biotin-labeled
thymine) binding to the same sequence containing the potential
thymine dimer was added and hybridized. The construct was bound
to magnetic particles derivatized with streptavidin. Two restriction
enzymes, Bgl1 and PVu1, were used to cut the immobilized
construct into a small 28mer and a large 7221mer DNA piece. The
small and large DNA fragments were spotted onto a positively
charged nylon membrane and treated with a specific anti cis-syn
dTddT dimer antibody and a second antibody, HRP-labeled, to
recognize the first one. As depicted in Figure 1, the chemilumi-
nescence reaction is clearly limited to the spot containing the 28mer
DNA, showing that the PNA reagent was able to recognize
Supporting Information Available: Experimental protocols and
characterization data. This material is available free of charge via the
References
(1) Taylor, J. S. Acc. Chem. Res. 1994, 27, 76-82.
(2) Friedel, M. G.; Cichon, M. K.; Carell, T. In CRC Handbook of Organic
Photochemistry and Photobiology, 2nd ed.; Horspool, W., Lenci, F., Eds.;
CRC Press: Boca Raton, FL, 2004; pp 141/141-141/122.
(3) Begley, T. P. In ComprehensiVe Natural Products Chemistry; Poulter, C.
D., Ed.; Elsevier Science B. V.: Amsterdam, The Netherlands, 1999; Vol.
5, pp 371-399.
(4) Taylor, J. S. Pure Appl. Chem. 1995, 67, 183-190.
(5) Schaerer, O. D. Chem. Inf. 2003, 34.
(6) Greenberg, M. M.; Barvian, M. R.; Cook, G. P.; Goodman, B. K.; Matray,
T. J.; Tronche, C.; Venkatesan, H. J. Am. Chem. Soc. 1997, 119, 1828-
1839.
(7) Karplus, M.; Yang, W.; Banerjee, A.; Verdine, G. Nature 2005, 31, 612-
618.
(8) de Padula, M.; Slezak, G.; Auffret van Der Kemp, P.; Boiteux, S. Nucleic
Acids Res. 2004, 32, 5003-5010.
(9) Friedberg, E. C.; Walker, G. C.; Siede, W. DNA Repair and Mutagenesis;
ASM Press: Washington, D.C., 1995; Vol. 1.
(10) Jans, J.; Schul, W.; Sert, Y.-G.; Rijksen, Y.; Rebel, H.; Eker, A. P. M.;
Nakajima, S.; van Steeg, H.; de Gruijl, F.-R.; Yasui, A.; Hoeijmakers, J.
H. J.; van der Horst, G. T. J. Curr. Biol. 2005, 15, 105-115.
(11) Taylor, J.-S.; Brockie, I. R.; O’Day, C. L. J. Am. Chem. Soc. 1987, 109,
6735-6742.
(12) Smith, C. A.; Taylor, J.-S. J. Biol. Chem. 1993, 268, 11143-11151.
(13) Douki, T.; Court, M.; Sauvaigo, S.; Odin, F.; Cadet, J. J. Biol. Chem.
2000, 275, 11678-11685.
(14) Carty, M. P.; Lawrence, C. W.; Dixon, K. J. Biol. Chem. 1996, 271, 9637-
9647.
(15) Gut, I. G.; Wood, P. D.; Redmond, R. W. J. Am. Chem. Soc. 1996, 118,
2366-2373.
(16) Fo¨rster, T. Discuss. Faraday Soc. 1959, 7-17.
(17) Nielsen, P. E.; Egholm, M. Peptide Nucleic AcidssProtocols and
Applications; Horizon Scientific Press: Wymondham, UK, 1999.
(18) Thomson, S. A.; Josey, J. A.; Cadilla, R.; Gaul, M. D.; Hassman, C. F.;
Luzzio, M. J.; Pipe, A. J.; Reed, K. L.; Ricca, D. J.; Wiethe, R. W.; Noble,
S. A. Tetrahedron 1995, 51, 6179-6194.
JA056358I
9
J. AM. CHEM. SOC. VOL. 128, NO. 5, 2006 1405